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ABSTRACT 
Purpose: Behaviour change interventions are more likely to be effective if they are sensitive 
to contextual determinants of behaviour. Delayed presentation of women with breast symptoms 
is a concern for both high-income and low- and medium-income countries. Our aim was to 
integrate evidence on determinants of time to presentation of women with breast symptoms 
with complementary evidence on interventions for promoting early presentation.  
Methods: A systematic review was conducted according to PRISMA guidelines. Ten 
electronic databases were searched for relevant articles published between 1985 to May 2019. 
Pre-defined selection criteria were applied to retrieved records. Evidence on interventions, and 
on determinants were integrated through sequential explanatory synthesis design.   
Results: Of the 4185 documents retrieved, 11 intervention studies and 10 determinants studies 
were included in the synthesis. Overall, evidence on interventions is of low quality, while that 
on determinants is of medium quality. Intervention studies were mostly individual-level with 
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almost exclusive focus on breast cancer awareness among postmenopausal women in high-
income countries. Synthesis of evidence on determinants resulted in 10 domains. Juxtaposing 
the evidence on determinants of time to presentation of women with breast symptoms with one 
on the interventions to promote early presentation shows a mismatch between them.  
Conclusions: Whilst there is strong evidence that women with breast symptoms face multi-
level influences to presentation, current interventions have focused almost exclusively on 
breast cancer awareness in high-income countries. High quality multi-level interventions are 
required to promote early presentation of symptomatic women in different socio-cultural and 
economic settings.   




Breast cancer kills more than 627,000 women globally, and the incidence and mortality 
continues to rise (Bray et al., 2018).  Although it is the leading cancer in women in both  high- 
income countries (HICs) and low- and medium-income countries (LMICs), there are 
disproportionately higher mortality and poorer survival rates in LMICs (Anderson et al., 2011; 
Bray et al., 2018). There are many determinants of breast cancer outcomes, however,  the stage 
at diagnosis is generally recognized as the most important predictor of outcome  (WHO, 2014).   
In HICs, 30-38% of women present at stages 3 or 4, while in LMICs, 50-90% present at these 
stages (Anderson et al., 2011). Evidence strongly suggests that delay of three months or more 
is associated with poorer outcomes (Neal et al., 2015; Richards et al., 1999a; Richards et al., 
1999b). Population-based mammography screening for breast cancer is not cost-effective for 
LMICs, hence early symptomatic presentation is recommended for such settings (WHO, 2014). 
Symptomatic presentation is a greater priority for LMICs where most women present 
with advanced disease, but HICs are also focusing on it through early diagnosis initiatives 
to further improve patient outcomes (Richards et al., 1999b; Rubin et al., 2015).   
Women experience two stages before treatment is initiated following self-discovery of 
breast symptoms: patient and provider intervals (Scott et al., 2013; Weller et al., 2012). Patient 
interval is the time between discovery and first contact with a healthcare professional (HCP) 
for the evaluation of symptoms, while provider interval is the time from first contact to the 
initiation of treatment (Scott et al., 2013). Patient interval has greater influence on the stage at 
diagnosis than provider interval because most cancer diagnoses come from symptomatic 
presentation of patients (Rubin et al., 2015). This systematic review is concerned with the 
patient interval.  
Previous systematic reviews on delays by symptomatic women indicate that the focus 
has been on specific ethnic populations, age groups, and  geographical regions; while others 
were conducted over five years ago (Bish et al., 2005; Jones et al., 2014; Ramirez et al., 1999; 
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Sharma et al., 2012). Moreover, other reviews have only synthesised evidence on interventions 
to promote early symptomatic presentation (Austoker et al., 2009; O'Mahony et al., 2017). It is 
not known if the current interventions match with multi-level determinants of symptomatic 
women’s help-seeking behaviour in diverse socio-cultural and economic settings. Secondly, to 
our knowledge, this is the first review to integrate evidence on barriers to, and facilitators of, 
early presentation with evidence on interventions for promoting early presentation. 
The aim of this systematic review was to integrate worldwide evidence on determinants 
of time to presentation of women with breast symptoms, with complementary evidence on 
interventions for promoting early presentation. The review was guided by the following 
questions: (a) what are the patient-level determinants of help-seeking behaviour among 
women with breast symptoms? (b) what are the healthcare system barriers to, and facilitators 
of, early presentation in this population, and (c) what interventions have been used to promote 
early presentation of women with breast symptoms? 
2. Methods 
This systematic review was conducted according to the Preferred Reporting Items for 
Systematic Reviews and Meta-Analysis (PRISMA) guidelines (Moher et al., 2009). A 
sequential explanatory synthesis design (Figure 1: Sequential explanatory synthesis design), 
developed by the Evidence for Policy and Practice Information (EPPI) centre was adopted 
(Oliver et al., 2005; Thomas et al., 2004).  
2.1.  Search strategy  
Ten databases (Medline, CINAHL, SSCI, ASSIA, Cochrane register of controlled trials 
(CENTRAL), Cochrane Breast Cancer Group’s Specialized Register (CBCG), World 
health organisation clinical trials registry platform (ICTRP), Clinicaltrials.gov, HINARI, 
and Google Scholar) were searched for the period between January, 1985 and May 2019. 
The search was initially undertaken between 1st May 2015 and 14th June 2015, and was re-run 
in May 2019.  Aggregated results from both searches are reported in this review. 
A search strategy was developed iteratively.  First, a scoping review was conducted on 
two databases (MEDLINE, CINAHL) to identify index terms, ‘free text’ terms, and keywords 
contained in the titles and abstracts of relevant papers. Additionally, the search strategy was 
piloted on five databases with the goal of identifying additional ‘free-text’ terms, 
controlled search terms and phrases.  A search strategy was developed and run in 
MEDLINE (Table 1: Search strategy for MEDLINE) and adapted for other databases. 
Hand-searching was undertaken on reference lists of included studies.  
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2.2. Eligibility criteria  
 All studies, irrespective of design, had to meet the following inclusion criteria: were 
conducted with women (≥ 18 years of age), reported in English, and published as primary 
research articles in peer-reviewed journals between 1985 and May 2019. Thereafter, specific 
criteria were applied to both the intervention and the barriers/facilitators studies. 
Intervention studies were included in the review if they: 
• reported on interventions that aimed at promoting early presentation of 
women with breast symptoms; 
• had the primary outcomes of earlier stage at presentation or change in 
knowledge, skills, behaviour, beliefs, attitude  that would potentially 
promote early presentation of women with breast symptoms; 
• employed   randomised controlled trials, non-randomised controlled trials 
and quasi-experimental designs. Observational and descriptive studies were 
also considered due to the limited evidence on this topic.   
Barriers/facilitators studies were included in the review if they: 
• reported  barriers to, and/or facilitators of, early presentation of women 
with breast symptoms; 
• collected data before women had their first contact with a healthcare 
professional; 
• were quantitative, qualitative or mixed method studies. 
We excluded full-text publications on barriers/facilitators that focused on women 
diagnosed with breast cancer (35); asymptomatic women (4); mixed cancers (4); used 
secondary data (3); and used a mixed sample, diagnosed with breast cancer and 
symptomatic (3) among other reasons as shown in figure 2. Additionally, one ongoing 
trial, and another that measured knowledge of breast cancer screening tools and early 
detection practices were also excluded. 
2.3. Study selection and data extraction procedures  
Following deduplication, one author (P.K) screened the articles for eligibility through 
a two-stage process (Figure 2: PRISMA flowchart). 
 Articles were selected based on titles and abstracts that met the eligibility criteria. Where the 
inclusion criteria were met, full documents were retrieved for second stage screening. In the 
second stage, full documents were reviewed on the same eligibility criteria. During both stages, 
a 10% random sample was chosen for review by an independent reviewer (E.L), and any 
disagreements were resolved by consensus. An inter-rater reliability of 97% was achieved at 
both stages.   
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Two data extraction forms (for intervention, and barriers/facilitators studies), 
specifically designed for this review, were developed and pilot tested. One reviewer (P.K) 
initially extracted the data and a second reviewer (E.L), independently counterchecked the data 
for accuracy and completeness. Extracted information for the barriers/facilitators studies 
included: citation details, country classification, and setting, type of study, methods, sampling, 
participants’ characteristics, and findings. For the intervention studies, the information 
extracted included: citation details, country classification, setting, and type of study, methods, 
participant characteristics, content, aim and timing of intervention, theoretical underpinning of 
intervention, comparison/control group, outcome measures, and results.  
2.4. Study methodological quality appraisal  
The selected articles were initially appraised by one reviewer (P.K) and the second 
reviewer (E.L) independently counterchecked the accuracy of quality appraisal results. Any 
discrepancies identified were resolved by consensus. The included studies adopted diverse 
research designs.  Barriers/facilitators studies either adopted qualitative or quantitative design, 
while intervention studies were either RCTs or non-RCTs.  
The Critical Appraisal Skills Programme [CASP] (2013)  was adopted for quality appraisal of 
included qualitative studies (Gough et al., 2017). The quantitative studies on barriers/ 
facilitators were appraised using six generic criteria (Jones et al., 2014; Pluye et al., 2009). 
These six generic criteria were: clear aims of the research, appropriateness of research design, 
clarity of research methods, appropriateness of analytical methods, attempt to control 
confounding variables, and adequacy of data relative to conclusions and interpretations.  All 
barriers/facilitators studies, regardless of their appraisal outcome were included in the 
synthesis, but studies of low quality were given less weight in the discussion of the findings. 
(Supplementary file 1 and 2).  Quality appraisal of the intervention studies was conducted 
using the Cochrane Collaboration Risk of Bias Tool for the RCTs   (Higgins and Green, 2011), 
and the Effective Practice and Organisation of Care (EPOC) review group risk of bias criteria 
for the non-RCTs (Cochrane EPOC Group, 2013) ( Supplementary file 3 and 4). The 
adoption of different quality appraisal tools was informed by the diverse designs of 
included studies.  
2.5.Data synthesis  
Three types of data synthesis were performed. First, owing to heterogeneity of 
intervention studies, meta-analysis was not feasible, and a narrative synthesis was performed. 
This involved textual description of the characteristics and findings of intervention studies in 
view of the review questions (Popay et al., 2006). Thematic synthesis of barriers/facilitators 
studies was performed in three phases: ‘line-by-line coding’, development of ‘descriptive 
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themes’, and generation of ‘analytical themes’ (Thomas and Harden, 2008). Lastly, cross-study 
data synthesis was conducted according to Evidence for Policy and Practice Information (EPPI) 
Centre approach  for combining qualitative/quantitative and interventions evidence 
(Thomas et al., 2004). A matrix (Table 5: Comparison between “implications for 
intervention development” and current interventions to promote early presentation) was 
used to compare the extent to which current interventions have addressed women’s views 
regarding determinants of early presentation.  
3. Results 
3.1.Results of the search 
Twenty one studies were included in the review. Of these, 11 were intervention studies 
(Table 2: Included Intervention studies: Setting, Type of study, Methods, Intervention 
content, Quality of evidence), and 10 others investigated barriers/facilitators to women’s 
presentation with breast symptoms (Table 3: Included Barriers/Facilitators Studies: 
Methodological Characteristics).  
3.2. Description of intervention studies  
Sample size and setting: Sample sizes in five of the included studies ranged from 20 to 
286 participants (Burgess et al., 2008; Burgess et al., 2009; Forbes et al., 2011; Forster et al., 
2014; Mena et al., 2014). Five studies investigated larger samples of between 356 and 867 
women (Campbell et al., 2016; Dodd et al., 2017; Forbes et al., 2012; Linsell et al., 2009; 
Zonouzy et al., 2019). One study did not report the number of women targeted by the 
intervention (Devi et al., 2007). Of the 11 studies, only three were conducted in LMICs (Devi 
et al., 2007; Mena et al., 2014; Zonouzy et al., 2019). 
3.2.1. Risk of bias of included studies  
Overall, the methodological quality of the studies was low, with nine having either 
unclear risk of bias or high risk of bias (Burgess et al., 2008; Campbell et al., 2016; Devi et al., 
2007; Dodd et al., 2017; Forbes et al., 2012; Forbes et al., 2011; Forster et al., 2014; Mena et 
al., 2014; Zonouzy et al., 2019). The detailed results of risk of bias of studies is shown in Table 
2: (Included Intervention studies: Setting, Type of study, Methods, Intervention content, 
Quality of evidence).   
3.2.2.  Interventions 
All but three studies targeted women who were invited for mammography screening, 
while the three targeted women in the general population (Devi et al., 2007; Mena et al., 2014; 
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Zonouzy et al., 2019). All the interventions were educational programmes using a range of 
teaching strategies.  
The duration of   most individual-level interventions ranged from one month to twelve months 
(Burgess et al., 2008; Burgess et al., 2009; Campbell et al., 2016; Dodd et al., 2017; Forbes et 
al., 2012; Forster et al., 2014; Linsell et al., 2009), with one being implemented for two years 
(Forbes et al., 2011). There were three community-level interventions, with one lasting five 
years from 1993 to 1998 (Devi et al., 2007), while another one lasted for three months 
(Zonouzy et al., 2019) . The duration of implementation of the remaining intervention under 
this category was not specified (Mena et al., 2014).  
3.2.3.  Effects of interventions  
 Primary outcomes 
Eight of the intervention studies had a primary outcome as  breast awareness (Burgess 
et al., 2008; Burgess et al., 2009; Campbell et al., 2016; Dodd et al., 2017; Forbes et al., 2012; 
Forbes et al., 2011; Forster et al., 2014; Linsell et al., 2009).  One intervention study (Mena et 
al., 2014) had knowledge, attitude and practice as the primary outcomes; while another (Devi 
et al., 2007) had down-staging of breast cancer from stage 3 or 4 to 1 or 2 at the point of 
presentation as its primary outcome. The remaining intervention had attitude, behavioural 
intention and behaviour as the study outcomes (Zonouzy et al., 2019). 
Booklet plus 10-minute interaction or nudge stickers 
Seven individual-level intervention studies  (Burgess et al., 2008; Burgess et al., 2009; 
Campbell et al., 2016; Dodd et al., 2017; Forbes et al., 2012; Forbes et al., 2011; Linsell et al., 
2009) used a booklet plus a 10-minute interaction; while one ((Forster et al., 2014) used a 
booklet plus three nudge stickers.  All the intervention studies in this category had breast 
awareness as the primary outcome. For all intervention studies, at one month post intervention 
a higher proportion of women could correctly identify five or more non-lump breast symptoms, 
and were more confident in breast checking.  However, after six or twelve months, some 
interventions reduced in their effectiveness, although the measures still remained higher than 
in the pre-intervention period (Burgess et al., 2009; Campbell et al., 2016; Linsell et al., 2009).  
Public breast awareness campaigns 
There were three interventions in this category. The down-staging programme reduced 
the proportion of women presenting for treatment at a late stage (stages 3 and 4) from 77% 
(69/90) in 993 to 37% (42/115) in 1998 (ᵡ²=17.0; p<0.0001) (Devi et al., 2007). The other 
community-based intervention focused on knowledge, attitude and practices and had mixed 
results (Mena et al., 2014). The study reported that women in the intervention community 
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gained more knowledge about: breast symptoms (82.3% vs 53.5%), genetical vulnerability to 
breast cancer (23.8% vs 9%), and importance of breast self-examination (90% vs 59.4) than 
referent community. However, both the intervention and the referent communities seemed to 
score similarly when it came to a belief that breast cancer is caused by evil spirits, or is an 
infectious disease. The third study reported significant differences between the two study 
groups post-intervention, indicating that the intervention group showed significant 
improvements in attitudes (P=0.03) and behavioural intention (P=0.01) but not for behaviour 
(Zonouzy et al., 2019). 
3.3. Description of barriers /facilitators  studies  
Ten studies on barriers/facilitators met the inclusion criteria, and their methodological 
characteristics are summarised in Table 3 :( Included Barriers/Facilitators Studies: 
Methodological Characteristics). All except one study were conducted in HICs (Khakbazan 
et al., 2014), which restricts generalizability of results to LMICs. Furthermore, most studies on 
barriers/facilitators is that most of them are atheoretical with only three using a 
theoretical/conceptual framework to underpin the study (Friedman et al., 2006; O'Mahony et 
al., 2011; O'Mahony et al., 2013).  Only two studies were considered as being of low quality, 
while the rest were either of medium or high quality (Lam et al., 2009b; Li et al., 2012).  
3.3.1 Determinants domains    
A thematic synthesis of literature produced 33 free codes, which were organised into 
10 descriptive themes. A higher level of abstraction organised the 10 themes in hierarchical 
order to produce five analytical themes as shown in figure 3: (Multi-level conceptual model 
on determinants of presentation of women with breast symptoms). Determinants of 
delayed presentation of women with breast symptoms are described under the 10 descriptive 
themes.   
Knowledge about breast symptoms  
Women reported several aspects of knowledge about breast symptoms. Some thought 
that their painless breast lump was caused by either the Chinese medicine they had used,  
pathology of  organs adjacent to breast, pre-existing chronic illness, or self-medication 
(Khakbazan et al., 2014; Lam et al., 2009a; Lam et al., 2009b; Li et al., 2012).   
Furthermore, prior experiences or habits such as having had abortion/termination of 
pregnancy, traumatic bruising of the breast, wearing an underwire bra, smoking, and eating a 
poor diet were also reported by women as causes of breast cancer (Facione and Facione, 2006). 
Women who had no such experiences or habits delayed help-seeking, while those who had, 
thought they would reverse their breast symptoms by ceasing these habits. Moreover, some 
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women delayed if there was a mismatch between their pre-conceptions and how breast cancer 
actually presented (Facione and Facione, 2006; Lam et al., 2009a).  
Another aspect of knowledge is how women interpreted their symptoms. Those who 
delayed often interpreted them as harmless, temporary, and judged that they did not require 
medical attention (Li et al., 2012; Nosarti et al., 2000; O’Mahony and Hegarty, 2009). Even 
for some who sought help, they did so for a primary health problem, with  breast symptoms 
presented as secondary (Lam et al., 2009a; Lam et al., 2009b; Li et al., 2012). 
Lump-symptoms were interpreted  as being associated with breast cancer, and  prompted more 
help- seeking behaviour than non-lump symptoms such as indrawn nipple, hot red area, 
persistent itching, and skin changes (Khakbazan et al., 2014; Lam et al., 2009a; Nosarti et al., 
2000; O'Mahony et al., 2013). Moreover, the characteristic of the breast lump was an important 
influence on help-seeking behaviour. Those who had painful breast lumps were more likely to 
seek help promptly than those who had painless breast lumps (Khakbazan et al., 2014; Lam et 
al., 2009a; Nosarti et al., 2000; O'Mahony et al., 2013).This was partly because women 
attributed non-painful lumps to normal physiology such as breastfeeding or normal hormonal 
variations (Khakbazan et al., 2014; Lam et al., 2009a). Lastly, worsening of symptoms, 
development of new ones, and the interference with women’s daily activities prompted help-
seeking, while apparent fluctuation prompted delay (O'Mahony et al., 2011).  
Emotional and psychological responses to breast symptoms  
Overall, emotional and psychological reactions to breast symptoms inhibited help-
seeking rather than promoted it. Those women who responded to their breast symptoms with 
fear, anxiety, worry, uncertainty and who perceived a threat of death, sought help as a means 
of controlling uncertainty, negative emotions and to avoid a possible poorer prognosis (Facione 
and Facione, 2006; Khakbazan et al., 2014; Lam et al., 2009a; Lam et al., 2009b). Whilst these 
are general emotional reactions, some women specifically delayed for fear of surgical treatment 
(Facione and Facione, 2006; Friedman et al., 2006; Nosarti et al., 2000). Significantly, women 
who reported contrary emotions such as reduced fear, indifference, and an optimistic 
perspective also delayed help-seeking (Khakbazan et al., 2014; Li et al., 2012). 
Defence mechanisms of suppression and denial were used by some women to avoid 
confronting a potential cancer diagnosis, and its implications (Friedman et al., 2006; 
Khakbazan et al., 2014; Lam et al., 2009a; Lam et al., 2009b; Li et al., 2012; Nosarti et al., 
2000; O'Mahony et al., 2011).  
Beliefs and attitudes about breast cancer 
Beliefs and attitudes about breast symptoms were largely shaped by past experiences 
with any cancer, religious beliefs, and myths. Fatalism, religious beliefs and negative past 
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cancer experiences made women view breast cancer as incurable and a ‘death sentence’ 
(Facione and Facione, 2006; Lam et al., 2009a; O'Mahony et al., 2011; O'Mahony et al., 2013). 
Some women resigned to their fate, resorting to prayers for God to cure them of their symptoms 
(Lam et al., 2009a; O'Mahony et al., 2011; O'Mahony et al., 2013).  
Women who had in the past interacted with family members, relatives, friends and neighbours 
who had a breast cancer diagnosis tended to seek help more promptly than those who had no 
such experience (Facione and Facione, 2006; Friedman et al., 2006; Khakbazan et al., 2014; Li 
et al., 2012; O'Mahony et al., 2011).Women who had heard positive stories about early 
diagnosis and treatment from breast cancer survivors were more likely to seek help promptly 
(Facione and Facione, 2006; O'Mahony et al., 2011). 
Competing obligations and self-care  
Competing obligations such as child care, work-related, and professional commitments 
took precedence over help-seeking (Facione and Facione, 2006; Friedman et al., 2006; 
Khakbazan et al., 2014; Lam et al., 2009a; Lam et al., 2009b; Li et al., 2012; O'Mahony et al., 
2011; O'Mahony et al., 2013). Women who had established self-care routines were more 
sensitive to bodily changes and promptly sought help on discovery of breast symptoms 
(Khakbazan et al., 2014).  
Socio-demographic characteristics  
Lower educational attainment and lower family incomes were associated with delayed 
help-seeking (Facione and Facione, 2006; Friedman et al., 2006; Khakbazan et al., 2014; Lam 
et al., 2009b; Li et al., 2012). Three studies reported that younger women were more likely to 
delay help-seeking than older women (Facione and Facione, 2006; Friedman et al., 2006; Li et 
al., 2012). 
Social networks 
Disclosure of breast symptoms to one’s social networks had different impacts on help-
seeking behaviour. To most women, disclosure to family members, relatives, friends and 
neighbours, helped them to interpret the symptoms more accurately, cope with psychological 
and emotional reactions, and help them in decision-making about help-seeking (Facione and 
Facione, 2006; Khakbazan et al., 2014; Lam et al., 2009a; Lam et al., 2009b; O'Mahony et al., 
2011).  At times the decision on seeking healthcare services was taken by a member of the 
social network rather than the woman herself (Lam et al., 2009b). However, in some instances, 
disclosure resulted in delayed presentation due to false reassurance and misinformation from 
social networks (Facione and Facione, 2006; Khakbazan et al., 2014). 
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Symptom impact on daily life and family 
The occurrence of distressing symptoms and their interference with daily activities 
prompted women to seek help (Lam et al., 2009a; Lam et al., 2009b). In particular, the fear of 
their husbands leaving them as a consequence of them losing a breast made them delay seeking 
help.  (Facione and Facione, 2006).  
Relationship with healthcare professionals   
Women reported that past experiences of discrimination, disrespect, frustration and 
prejudice with HCPs made them delay seeking help for the current health problem (Facione 
and Facione, 2006; O'Mahony et al., 2011; O'Mahony et al., 2013).  Other negative past 
experiences with HCPs reported in these studies were dismissal of symptoms as frivolous, 
ridicule, and criticism when they sought to schedule an appointment. Lastly, women reported 
feelings of shame and embarrassment when they anticipated that their breast symptoms would 
only be evaluated by a male instead of a female HCP (Khakbazan et al., 2014; Li et al., 2012; 
O'Mahony et al., 2011).  
Cost of healthcare services  
The high cost of healthcare relative to the patient/family incomes made women delay 
help-seeking so that they would be able to  meet their other basic needs (Friedman et al., 2006; 
Lam et al., 2009a; Lam et al., 2009b; O'Mahony et al., 2013).  
Healthcare infrastructure   
Some women attributed their delay to general unfamiliarity with healthcare services 
(Khakbazan et al., 2014; Lam et al., 2009a; Lam et al., 2009b; Li et al., 2012).   This challenges 
were more common among older women and immigrants. Moreover, other help-seeking 
barriers reported include difficulty in making appointments, appointment delays, irregular 
presence of doctors, and short opening hours (Friedman et al., 2006; Khakbazan et al., 2014; 
Li et al., 2012; O'Mahony et al., 2013).  
3.4. Cross-study results   
The 10 determinants domains on barriers/facilitators helped identify ‘implications for 
intervention development’ as shown in Table 4: (Barriers, Facilitators and “implications 
for intervention development” to promote early presentation among symptomatic 
women). In total, 15 implications were identified. A synthesis matrix was used to juxtapose 
implications alongside primary outcomes of intervention studies to examine the extent to which 
barriers/facilitators have informed the development of current interventions as shown in Table 
5 : (Comparison between “implications for intervention development” and current 
interventions to promote early presentation). Since some themes had more than one 
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implication, the numbers against each intervention indicates the specific implication being 
addressed by that particular intervention. Low breast cancer awareness has been addressed by 
two reliably evaluated interventions (Burgess et al., 2009; Linsell et al., 2009), and one other 
evaluated intervention (Forbes et al., 2012). Moreover, negative social, cultural 
constructions of breast cancer, unhealthy beliefs and practices, and importance of early 
presentation have been addressed by three other evaluated interventions (Devi et al., 2007; 
Mena et al., 2014; Zonouzy et al., 2019). Overall, only five out of 15 implications for 
intervention development have been addressed by any of the interventions, and only two 
interventions (Burgess et al., 2009; Linsell et al., 2009) have been reliably evaluated.  
4. Discussion 
Breast cancer in women remains a global health issue. Early detection and treatment 
has been linked to favourable outcomes. Most cancer diagnoses come from women presenting 
symptomatically rather than through screening, particularly in LMICs. This systematic review 
identified some of the barriers to, and facilitators of, early presentation of women with breast 
symptoms, and illustrated to what extent they have been addressed by current interventions.   
4.1. Barriers/Facilitators studies  
The quality of evidence on barriers/facilitators studies is adequate to inform the 
development of early presentation interventions, particularly for HICs because only one study 
was from LMICs (Khakbazan et al., 2014). Women reported multi-level contextual factors that 
may be broadly divided into patient-related determinants and healthcare system-related 
determinants. The major patient-related determinants reported by women related to knowledge 
about breast symptoms, social networks, reactions to symptom discovery, and beliefs and 
attitudes about breast cancer. The healthcare system determinants included cost of healthcare 
services, structure of healthcare system and women’s past experience with healthcare 
professionals. Most determinants reported appear to influence appraisal interval rather than 
help-seeking interval. This agrees with  previous studies which have reported that symptom 
appraisal phase account for more than two thirds of the patient delay (Andersen et al., 1995; 
Jones, 1990)  
 All but two determinants (Cost of healthcare services and Healthcare infrastructure) 
were simultaneously acting as barriers to, and facilitators of, early presentation. These 
competing forces resulted in a dynamic and non-linear help-seeking behavioural pattern that 
caused differences in lengths of time each woman took to appraise the symptoms and seek 
healthcare. Though the  findings of this review  agree with previous review findings, there are 
setting-specific determinants of women’s delayed presentation (Jones et al., 2014; Ramirez et 
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al., 1999; Richards et al., 1999a), For instance, some women, particularly from China attributed 
the symptoms to Chinese medicine (Lam et al., 2009a; Lam et al., 2009b). 
4.2. Intervention studies  
There is a dearth of high quality evidence on interventions to promote early presentation 
of women with breast symptoms as suggested by current and previous reviews.  A previous 
review which considered any intervention design identified only four interventions (Austoker 
et al., 2009), while in a more recent Cochrane review of interventions (RCTs) for raising breast 
cancer awareness in women, only two studies met the inclusion criteria (O'Mahony et al., 
2017). Other than one interventions in this review, all the others  were based on the assumption 
that increase in breast awareness would ultimately result in women presenting earlier, with one 
community-level intervention  being  able to demonstrate a down-staging effect of 25%  fewer 
women presenting at stage 3 or 4 after 5 years post-intervention (Devi et al., 2007). This 
assumption may not be true as demonstrated by a recent study comparing cancer awareness 
among International Cancer Benchmarking Partner Countries (Forbes et al., 2013). This study 
demonstrated that whereas UK has the highest cancer awareness, it also  has the highest 
perceived barriers to symptomatic presentation, which perhaps may have led to poor 
performance in 1-year cancer survival rates compared to countries with a similar healthcare 
system.   
There is  almost exclusive focus  on  single-level interventions despite the fact that this 
review, and previous literature  has demonstrated that influences of  health-seeking  behaviour 
are multifactorial  (DiClemente et al., 2013; Richards and Hallberg, 2015). The eight 
individual-level interventions were specifically developed to target postmenopausal women in 
HICs, which limits their generalization to LMICs, where majority of women diagnosed with 
breast cancer are pre-menopausal. Nonetheless, evidence from current interventions indicates 
that they have the potential to increase breast awareness in postmenopausal women, especially 
in the short term.  
4.3. Integrating cross- study results  
 Juxtaposing barriers/facilitators alongside intervention studies allowed the 
examination of the extent to which the current interventions have addressed women’s needs. 
There was incongruence between reported barriers/facilitators to early presentation on one 
hand, and interventions to address them. Of the 15 ‘implications to intervention development’ 
arising from women’s views, only five have been addressed by any of the interventions 
included in the review. Such mismatches indicate that determinants of time to presentation may 
not have been identified within the settings where the interventions have been developed and 
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evaluated. Similar studies have reported such incongruences (Rees et al., 2006; Shepherd et al., 
2006). 
 This review has demonstrated that help-seeking behaviour of women with breast 
symptoms is influenced by multi-level determinants. These determinants may guide the 
identification of congruent behaviour change theories/models, and techniques, which would 
then inform the development of interventions to promote early presentation. Evidence suggests 
that behaviour change interventions  that  are underpinned by theory and  rigorous empirical 
evidence are more likely to be effective  (Michie et al., 2008; Richards and Hallberg, 2015).  
4.4.Review strengths and limitations  
A comprehensive search was conducted in  ten databases  to identify and select studies 
that met the inclusion criteria, assess their methodological quality, and synthesise evidence in 
accordance to PRISMA guidelines (Moher et al., 2009). Unlike previous reviews, this review 
used qualitative evidence to interrogate the evidence on current interventions in terms of their 
appropriateness for behavioural change among symptomatic women. A limitation of methods 
used in this review is that grey literature and non-English publications were excluded.  
5. Conclusions  
Early presentation of women with breast symptoms results in improvements of 
outcomes. Evidence strongly suggests that women’s symptomatic presentation is influenced 
by multi-level contextual factors. Whilst evidence from current interventions suggests that they 
have the potential to increase breast awareness, their impact on the stage of breast cancer at 
presentation is uncertain because their exclusive focus on individual-level determinants leaves 
other influences of women’s help-seeking behaviour unaddressed.  Furthermore, results from 
intervention studies included in this review should be interpreted with caution as most of them 
are of low quality. Moreover, they are heterogeneous in terms of their design, content, 
outcomes measured, and the populations studied. Lastly, the interventions examined have 
exclusively focused on postmenopausal women in HICs, hence cannot be generalized to 
LMICs where the majority of women diagnosed with breast cancer are premenopausal.  
6. Implications for practice and future research  
The evidence identified in this review on determinants of help-seeking behaviour of 
symptomatic women may be considered by HCPs to inform development of multilevel 
interventions to shorten delays and promote early presentation. The predominantly individual-
level nature of interventions reported in this review, as well as their overall low quality, 
prevents a strong recommendation on policy and practice. Future research should focus on 
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rigorous development of multi-level interventions based on local socio-cultural contextual 
evidence on determinants of time to presentation of symptomatic women. This is particularly 
important for LMICs where screening services are unavailable and majority of women with 
breast cancer present at late stages. Furthermore, future studies may adopt longitudinal 
approaches to evaluate the impact of interventions on the stage of breast cancer at presentation 
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